Medtronic Inc (MDT) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Medtronic Inc (MDT)

80.83

-0.15 (0.19%)

as of Jun 29, 2026, 7:17:55 pm Market Open.

182 watching

Investor Insights

Jun 29, 2026, 12:00 am

This summary was created by AI, based on 2 opinions in the last 12 months.

Experts have mixed opinions on Medtronic Inc (MDT-N), with one reviewing it positively, stating that the company is set to capitalize on advancements in AI, alongside the strong market demographics of the Baby Boomer population. The other expert, however, is more skeptical, acknowledging that while MDT is making gains against competitors like Boston Scientific, it lacks the substantial R&D capabilities necessary for sustained leadership in the long run. There is caution expressed that the investment may not be suitable for those looking for a long-term hold, as the focus is more on trading amidst anticipated product launches that could support the stock's upward movement for up to 18 months. Ultimately, while MDT may have a diversified product range which provides some advantage, the lack of a strong R&D pipeline compared to its peers raises concerns about its future competitiveness.

Consensus

Neutral

Valuation

Undervalued

Similar

Stryker, SYK

PAST TOP PICK

(A Top Pick Jan 15/21, Down 7%) Company has increased dividend for almost 50 years, however needs a good acquisition to grow. Stock price is low which creates a buying opportunity. Will continue to buy and hold.

HOLD

Relatively low growth at 3-5%, value stock with a 13.5-14.5x multiple. Couple of missteps. Competitive threats. One of the largest medical device companies. Tends to attract money flows when markets get volatile. Reports later in February. Mild inflationary pressures. OK dividend. OK to hold over time, but if you want more growth, pair it with something like BSX.

SELL

They've been executing badly. Sell this and buy EW-N

WAIT

MDT vs. BSX Two great companies. In the implantable medical device business. Loves the area. Too expensive, as investors have flocked to them and the multiple has increased. Would love to own both if prices came down substantially.

BUY

Healthcare is an interesting area, especially with a slant toward medical devices. This is a safe and steady name, significant track record of dividend increases.

BUY

They report Thursday. Boring, but he predicts stellar numbers. Their medical devices are being installed in record numbers post-pandemic. There's a lot of pent-up demand from all these delayed surgeries.

BUY ON WEAKNESS

Allan Tong’s Discover Picks Up 14.68% since August 18, 2020 MDT was trading at $101. It has since climbed as high as $122.15, but now lockdowns are delaying elective surgeries, and the stock is starting to wobble around $117. Keep an eye on this, because continuing lockdowns and a general market pullback would make this a buy again. Right now, MDT is pricey, trading at a 43x PE, which is nearly double from last April and the highest level in 12 months. Its divvy pays nearly 2%. Analysts target the stock at $129.26, based on 17 buys and three holds. Read 2 Successful Past Picks: Nuvei & Medtronic for our full analysis.

TOP PICK

The global leader in med-tech space by revenue. It has increased dividends for 42 consecutive years. 9.4% total return for the last 5 years. Benefits from the aging demographics. Does a lot of tuck in acquisitions. The top line is growing at 9% in the last 10 years. (Analysts’ price target is $128.84)

BUY

Likes this medical device-maker. They presented at today's JPMorgan's healthcare conference. The stocked slipped 1% today after the company trimmed organic growth forecast this quarter because the explosion of Covid cases is forcing the postponement of medical procedures. This happened at a previous conference, so he's not surprised. The Covid issue is temporary and meanwhile more people will get vaccinated that will unleash pent-up demand for MDT's devices.

BUY

There is a backlog of elective surgeries. This is a good area of the industry to be in. She chose JNJ-N but MDT-N is a good candidate too.

BUY

A large medical tech company, one of the largest in that field. It is a nice industry that he likes. They deliver consistent earnings growth. It is more of an oligopoly market. It could be a core holding in a portfolio to get medical technology exposure. He holds BSX-N, however.

BUY ON WEAKNESS

Sales could be light, because people may be light, because it makes medical devices and people are postponing operations due to Covid. If MDT gets hit, buy it, because a Covid vaccine is coming. It reports Tuesday.

BUY

A premier medical device-maker. Their most recent report beat the street. These medical stocks sold off during the lockdown over fears that surgeries would halt indefinitely, but those fears and sell-offs were overdone.

BUY

Allan Tong’s Discover Picks The Medtronic Stock is one of the largest medical device companies on the globe. It pays a decent dividend of 2.3%, which has grown in the last 28 straight years. MED trades at a 22x PE and has a price target of $110.17, $8 higher than Monday’s trade. MED beat three of its last four quarters, missing its last reported EPS of 68 cents by 10 cents. It boasts a profit margin of 16.56%. Read Cybersecurity Stocks, Clean Energy Stocks and Medical Device Stocks: Little-Known Picks for our full analysis.

TOP PICK

One of the largest device companies in the world. There's a lot of pent-up demand coming for surgeries. It was $120, and now it's around $100. Should see $120 again. Yield is 2.29%. (Analysts’ price target is $110.50)

Showing 31 to 45 of 125 entries

Most Recent Experts

Chris White, CFA

5i Research

Jenny Harrington, CEO, Gilman Hill Asset Management

Gilman Hill Asset Management

Stephen Weiss, Founder, Short Hills Capital Partners

Short Hills Capital Partners

Kevin Simpson

Capital Wealth Planning

Bryn Talkington

Requisite Capital Management

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Medtronic Inc (MDT)